Summary The spontaneous reaction of 110 ILM chlorambucil (4-[p-[bis(2-chloroethyl) However, GTSs Al-I and A2-2 were associated with a significant increase of CHBSG at the expense of CHBSG2 + CHBSGOH suggesting that these GTSs sequestered CHBSG at the active site. This interpretation was supported by inhibition studies which showed that CHBSG was a pure competitive inhibitor of the activity of GSTs Al-l and A2-2 towards 1-chloro-2,4-dinitrobenzene with Ki's of 1.3 and 1.2 tiM respectively. GSH transferases P1-1 and Mla-la were inhibited by CHBSG above 10 LM.
Biochem. J., 282, 305) had little or no catalytic effect on these reactions as determined by loss of CHB. However, GTSs Al-I and A2-2 were associated with a significant increase of CHBSG at the expense of CHBSG2 + CHBSGOH suggesting that these GTSs sequestered CHBSG at the active site. This interpretation was supported by inhibition studies which showed that CHBSG was a pure competitive inhibitor of the activity of GSTs Al-l and A2-2 towards 1-chloro-2,4-dinitrobenzene with Ki's of 1.3 and 1.2 tiM respectively. GSH transferases P1-1 and Mla-la were inhibited by CHBSG above 10 LM.
Incubation of 2 tLM CHB, a concentration which may be of more significance for chemotherapy, in the presence or absence of GST A 1-2 (20-50 LM) showed catalysis of GSH monoconjugation equivalent to 18% of the spontaneous rate. However, the dominant effect again was the sequestration of CHBSG which reached 74.3 ± 1.5 (SEM)% of the total reactants at 60 min compared to 28.9 ± 0.3(SEM)% in controls. CHBSG, although possessing a potential electrophilic centre, showed no detectable alkylation of plasmid DNA but indirect evidence was obtained that it alkylated other cellular macromolecules.
It is concluded that the contribution of GSTs to catalysis of CHB detoxication will depend on factors not previously considered, namely the relative molarities of CHB, CHBSG and GSTs, and the cellular capacity to excrete CHBSG to relieve product inhibition.
Chlorambucil (4-[p-[bis(2-chloroethyl) amino]phenyl]-butanoic acid; CHB) is a cytototoxic drug used for the treatment of Hodgkin's and non-Hodgkin's lymphoma, chronic lymphocytic leukaemia and ovarian cancer. It is a bifunctional alkylating agent capable of causing inter-strand covalent linkage through nucleophilic sites in DNA, principally the N-7 of guanine. It reacts with other cellular nucleophiles including glutathione (GSH) to form a monoglutathionyl derivative, 4-[p-[N-2-chloroethyl CHB is a hydrophobic anion at physiological pH and was shown by Bank et al. (1989) to enter and leave leukaemic lymphocytes rapidly by simple diffusion. In plasma, CHB is stabilised by binding to albumin (Ehrsson et al., 1981) .
A major problem in the use of cancer chemotherapeutics is the development of cellular resistance and, in the case of alkylating agents such as CHB, numerous studies suggest that enhanced expression of glutathione transferases (GSTs) may contribute to such resistance. For instance: Lewis et al. (1988) found that amplification of an alpha class GST in a Chinese hamster ovary (CHO) cell line was associated with resistance to CHB and other nitrogen mustards; Puchalski and Fahl (1990) found increased resistance to CHB upon transfection of mouse and monkey cells with rat GSTs 1-1 (class alpha), 3-3 (class mu) or human GST P1-1 (class pi, for nomenclature of human GSTs see Mannervik et al., 1992) , and Johnston et al. (1990) found an inverse correlation between both GSH and total GST activity and CHB-dependent DNA adducts formed in vitro in human chronic lymphocytic leukaemic lymphocytes. In support of these observations, murine GSTs of alpha, mu and pi classes were shown by Ciaccio et al. (1990) to increase significantly the rate of formation of CHBSG in vitro at pH 6.5, and the alpha class enzyme also stimulated the second GSH conjugation. Recently, Ciaccio et al. (1991) have also observed catalysis of the GSH conjugaton of CHB by human GSTs of the alpha and pi classes. In contrast, the transfection of GST P1-I into NIH 3T3 cells failed to alter their sensitivity to CHB (Nakagawa et al., 1990) . Moreover, Leyland-Jones et al. (1991) failed to detect a decrease in CHB sensitivity in a human breast tumour cell line stably transfected with a human alpha class GSH transferase.
In order to resolve these apparent discrepancies, we have tested the ability of purified human GSTs to catalyse the detoxication of CHB in vitro under conditions more comparable to those in vivo. The results confirm a catalytic effect of alpha class GSTs but reveal that GSTs sequester the partially detoxified primary product, CHBSG which results in inhibition of catalysis in vitro.
Materials and methods
Preparation of GSTs GSH transferase P1-I was prepared from human kidney cytosol by GSH-agarose affinity chromatography according to Vander-Jagt et al. (1985) , the GSH transferase fraction being eluted with 20 mM GSH, 2 mM dithiothreitol, 0.1 M Tris-NaOH, pH 9.6, followed by anion-exchange fplc on a Mono Q (HR 5/5) column equilibrated in 20 mM Tris-HCI, pH 7.8 containing 5 mM 2-mercaptoethanol and 10% (v/v) glycerol and elution by a linear gradient of NaCI in this buffer. GSTs Mla-la, Al-i, Al-2 and A2-2 were prepared from human liver cytosol (HL 133) Tennessee Donor Services, Nashville, TN, USA). The GST pool was prepared by affinity chromatography as above and the alpha enzymes were then separated from GST Mla-la by hydroxy-apatite fplc. (HPHT column, Bio-Rad, Richmond, CA, USA) according to Hussey et al. (1986) . GST Mla-la was finally purified by anion-exchange fplc at pH 7.8 as described above for GST P1-1, while the alpha enzymes were similarly separated at pH 9.5 in 30 mM piperazine-HCI, 5 mM 2-mercaptoethanol, and 10% (v/v) glycerol as described by Cmarik et al. (1990) . Elution was with a linear gradient of NaCl in each case.
GST M3-3 was purified from human testis by the same method used for GST Mla-la above. Specific activities at 37°C towards 1-chloro-2,4-dinitrobenzene (CDNB) (Habig et al., 1974) were 155, 140, 132, 125, 270 and 35 iLmol min-' mg protein-' for GSTs P1-i, Al-i, Al-2, A2-2, Mla-la and M3-3 respectively.
The rat theta class enzyme, GST 5-5, was prepared from liver cytosol according to Meyer et al. (199la) . All GSTs were > 97% pure as judged by reverse phase hplc (Meyer et al., 1989) and were stored at -20°C until use.
Analysis of reaction of CHB with GSH CHB reaction was analysed by a method based on that of Ciaccio et al. (1990) . Samples were applied to 250 x 4.6 mm Dynamax C18 column (Rainin Instruments, Woburn, MS, USA). Eluent A was 0.1 M ammonium acetate (hplc grade) in 5% (v/v) methanol and eluent B was 0.1 M ammonium acetate in 90% (v/v) methanol. The column was operated at 1 ml min-' and equilibrated in eluent A. After injection of sample, products were eluted with a linear gradient from 0 to 100% B over 40 min. The eluent was monitored at 254 nm. The hydroxy-phosphoryl-and glutathionyl-derivatives were prepared by incubating chlorambucil for 1 h with water alone, 0.1 M sodium phosphate, pH 7.0, or phosphate buffer containing 5 mM GSH respectively. Each sample was separated by hplc as above. The identities of reaction products were confirmed by comparison with the analyses of Ciaccio et al. (1990) .
Incubations of CHB with GSTs
Incubations were carried out with concentrations of GSH, salts and GSTs which approximate those of cytosol. Thus the GST to be tested was thawed and both concentrated and desalted using a Centricon 10 (Amicon, Danvers, MA, USA) at 0-4°C into 140 mM KCI, 5 mM GSH, 10 mM Na phosphate, pH 7.0 (buffer A). In each case a control (minus enzyme) sample, consisting of an equal volume of the same buffer of final purification as the GSH transferase, was concentrated and desalted in parallel with the enzyme sample. Buffer A was kept under argon to maintain GSH in the reduced form. The concentration of GST was determined from its activity with an appropriate model substrate immediately prior to incubation with chlorambucil. Chlorambucil in dry dimethylformamide (1 mg ml-') was added (3.5% v/v, final concentration 110 EM) to the test sample containing GST in a capped polypropylene vial at 0-4°C. Final assay volumes were from 60 to 120 l. A measured aliquot was immediately removed and added to an equal volume of 10% (v/v) perchloric acid to give a zero time sample and the remainder was incubated at 37°C for 5 or 35 min and the reaction terminated with acid as above. Samples were clarified by microcentrifugation and the unreacted CHB and its reaction products were separated by reverse phase hplc (see above) and quantitated from the A254 by integration (Reeve Analytical, 34 Chapel St, Glasgow, Scotland) . Since the chromophore of CHB is unaltered during these reactions, the molar proportions of CHB and its products were determined directly from the integrated absorbances at 254 nm. The bulk of the products were the monoand di-glutathionyl-conjugates (CHBSG and CHBSG2) together with a small amount of mono-hydroxy, monoglutathionyl conjugate (CHBSGOH). In contrast to the assays of Ciaccio et al. (1990) carried out in 100mM phosphate buffer, the phosphate derivatives were negligible (see Figure  1 ). The zero time sample was analysed and used as a check that 100% of CHB and metabolites were recovered from incubated samples. The amounts of CHB, CHBSG, CHBSG2 and CHBSGOH were then expressed as the mole per cent of their total.
In subsequent experiments the chlorambucil concentration was reduced to within the range expected intracellularly in vivo. Thus 1 ml assays contained 2 JLM chlorambucil (added from a stock of 0.1 mg ml' of dry dimethylformamide) in buffer A with or without the heterodimeric human GST A1-2. Aliquots were removed at 0, 35 and 60 min and analysed as described above.
To test whether S-hexyl glutathione would inhibit the effects of GST A1-2 on CHB reaction, 0.4 ml assys were carried out for 60 min with 4 tLM CHB and either 12 i4M or 100 ylM S-hexyl glutathione and analysed as described above.
To test whether the effect of GST A1-2 on CHB reaction might be modified by the presence of cellular macromolecules, the following fraction was prepared: 2 ml human kidney cytosol, from which the GSTs had been removed by passage through GSH-agarose, was dialysed for 48 h at 0-4°C (three changes) against 0.1 M KCI, 2 mM dithiothreitol, 10% glycerol, 10 mM Na phosphate, pH 7.0 to remove acid-soluble compounds which would interfere with the hplc analysis and then passed through a 1 ml column of Affi-gel blue equilibrated in this buffer to remove serum albumin (which stabilises CHB). For assay with CHB, a 0.3 ml aliquot of this crude macromolecule fraction was transferred into buffer A using a desalting Sephadex column (PD-10, Pharmacia-LKB, Uppsala, Sweden). The sample volume was 1.4 ml. A second aliquot was mixed with 0.3 ml purified GST A1-2 and similarly treated. Minutes Figure 1 Separation of chlorambucil and its glutathione conjugates by reverse phase hplc. One ml of buffer A containing 200 1M chlorambucil and 10% (v/v) dimethyl formamide was incubated at 37°C for 35 min and analysed by reverse phase hplc as described in the text. The products were identified from separate incubations of chlorambucil in water or in dilute phosphate-buffered saline which yield the hydroxy-and phosphoryl-products, but no GSH conjugates (Ciaccio et al., 1990) . tion was determined by the method of Bradford (1976) . These samples and controls containing only buffer A were then incubated with CHB and analysed as described above.
Inhibition studies CHB, CHBSG and CHBSG2 were collected from reverse phase hplc runs of a 1 ml incubation of 200 gM CHB in buffer A containing 10% (v/v) dimethylformamide. Control samples were also collected from appropriate positions on the gradient of a blank hplc run. GST activity with CDNB was determined in 250AlI of 1 mM GSH, 100 mM NaCl, 1O mM Na phosphate, pH 6.5 at 24°C using an MCC 340 Mk II microtiter plate reader (ICN-Flow, High Wycombe, Bucks, UK). Assays, in duplicate or triplicate, contained buffer, GSH transferase and 3% of appropriate hplc gradient solution with or without inhibitor. Reactions were initiated by addition of CDNB and the reaction monitored for 10 s at 340 nm. Enzyme inhibition was analysed using the Kinenort program kindly provided by Dr A.G. Clark.
100% of the added CHB showing a lack of covalent reaction with GSTs. Catalysis by GST Al-I was equivalent to only 5-10% of the non-catalytic rate at this pH. Surprisingly the increased level of CHBSG in the presence of GST Al-I was greater than expected from the loss of CHB, being associated with a decrease in formation of CHBSG2 and CHBSGOH. The increase of CHBSG in the presence of GST Al-I suggested that it was protecting this intermediate from further reaction through the well characterised capacity of GSTs as non-covalent binding proteins (Ketterer et al., 1978; Listowsky et al., 1988) . Similar effects on CHBSG accumulation are seen with GSTs A2-2, P1-I and Mla-la, but not GST M3-3.
The rat theta class enzyme, GST 5-5, used in lieu of its human equivalent, was also tested because it generally shows high activity towards a number of alkyl halides (Meyer et al., 1991a) but no catalysis of CHB-GSH conjugation was observed.
The apparent sequestration of CHBSG by GSTs Al-i, A2-2, Mla-la and P1-1 was investigated further by testing CHBSG and CHBSG2 as inhibitors of GST activity.
Alkylation ofguanine-N7 in plasmid DNA Chlorambucil, CHBSG and CHBOH were collected from an hplc separation as for the inhibition studies above. The methanol was removed by rotary evaporation under reduced pressure and the samples freeze-dried to remove ammonium acetate. After dissolving the compounds to approximately 10 JAM in dry dimethylformamide, their purity and concentration were determined by hplc analysis of an aliquot. The ability of CHB, CHBSG and CHBOH (0.1 and 0.33 mM) to alkylate guanine-N7 in the plasmid pBR322 was determined in 25 mM triethanolamine-HCI, pH 7.2 by the method of Hartley et al. (1986) .
Inhibition of GSTs
The activity of GSTs Al-l and A2-2 towards CDNB was inhibited by CHBSG. These assays last for less than 10 s so the instability of CHBSG is not significant. Dixon plots (e.g. Figure 3a ) and Hanes plots (e.g. Figure 3b ) indicated pure, competitive inhibition with respect to CDNB in each case with Ki's of 1.3 ± 0.2(SEM) JAM for GST Al-l and 1.2 ± 0.3 (SEM) JAM for GST Al-2. CHBSG2 was a less potent inhibi-
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Results Testing for catalysis of CHB-GSH conjugation by GSTs CHB (110 JAM) was incubated for 35 min at 37°C in a medium at pH 7.0 containing intracellular levels of salts, phosphate and GSH in the presence and absence of physiological concentrations of specific GSTs (Figure 2 ). In the absence of enzyme 61.7% of CHB had reacted with GSH and water yielding 39.8% CHBSG, 19.2% CHBSG2 and 2.7% CHBSGOH after 35 min. In the presence of individual GSTs, only GST Al-I (52 JM) showed significant catalysis as measured by the decrease in CHB remaining. Recovery of CHB, CHBSG, CHBSG2 and CHBSGOH was approximately GSTs were prepared and incubated with 110 gM CHB in physiological saline pH, 7.0 containing 5 mM GSH for 1 h at 37°C and the reaction products analysed by hplc all as described in the 'Methods'. Unshaded If the stabilisation of CHBSG by GST Al-2 is due to sequestration at the enzyme active site, the effect should be prevented by other inhibitors of activity. In Figure 5 is shown the results of inclusion of S-hexyl glutathione, an inhibitor of the l-chloro-2,4-dinitrobenzene GSH transferase activity with Ki 3 JAM (Mannervik & Danielson, 1988) on the reaction of 4 JAM CHB in the presence of 36 JAM GST Al-2. While 1O JM S-hexyl glutathione had no significant effect on CHB conjugation or CHBSG stabilisation by the GST, 100 jaM of the inhibitor completely prevented the effects of the GST. Thus, in a physiological situation the relatively high molarity of the GST is an important factor, low levels of inhibitor being insufficient to titrate the enzyme present with significant effect.
To test whether GST Al-2 could sequester CHBSG in the presence of other cellular constituents a crude soluble macromolecule fraction including proteins and nucleic acids was prepared from human kidney. Serum albumin was removed since it stabilises CHB (Ehrsson et al., 1981) . In Table I is shown the amounts of CHB and reaction products obtained in the presence and absence of the macromolecule fraction, CHBSGOH Figure 5 Effect of S-hexyl glutathione on the capacity of GST A1-2 to alter the reaction of CHB with GSH CHB (2 gM) was incubated at 37'C in physiological saline pH 7.0 containing 5 mM GSH for 60 min alone (open bars), with 36 gm GST A1-2 (shaded bars), with GST Al-2 + 1O jiM S-hexyl glutathione (diagnonal bars) or with GST Al-2 + 100LM S-hexyl glutathione (horizontal bars). Error bars indicate SD. Significant differences (Student t-test) are given by: *P <0.05; **P <0.002; ***P <0.001.
and the effect of inclusion of 30 JAM GST Al-2. In the presence of the macromolecule fraction (12 mg protein' ml-') but without GST A1-2, only 58.8% of the drug was recovered as CHB, CHBSG, CHBSG2 and CHBSGOH. Losses are presumably due to alkylation of macromolecules.
A comparison between the yield of CHBSG and (CHBSG2 plus CHBSGOH) in the presence and absence of the macromolecule fraction indicates that components of the macromolecule fraction are alkylated not only by CHB but also by CHBSG. In the presence of GST Al-2 the recovery of CHB and its GSH reaction products is increased to 80.9% and significant catalysis of GSH conjugation and stabilisation of CHBSG are observed.
Alkylation ofguanine-N7 In order to assess the toxicological significance of the sequestration of CHBSG, its ability to alkylate DNA was compared with that of CHB and CHBOH. The autoradiographs showed that, while CHBOH alkylated the plasmid as efficiently as CHB at 0.1 and 0.33 mM, CHBSG gave no detectable DNA alkylation under these conditions (data not shown). GST Al-2 in physiological saline, pH 7.0 containing 5 mm GSH for 35 min (single assays) or 60 min (five assays) and products analysed by hplc all as described in the 'Methods'. Unshaded bars, no GST added; shaded bars, plus GST Al-2. Error bars indicate SD. Significant differences (Student t-test) are given by: *P<0.02 and **P<0.001.
Discussion
The results confirm the findings of Ciaccio et al. (1991) that human alpha class GSTs catalyse the first GSH conjugation of CHB. However, it is also shown that an important effect, particularly at low concentrations of CHB, is the noncovalent sequestration of the primary product CHBSG. This also occurs with GSTs P1-1 and Mla-la but the alpha class GSTs are most sensitive to CHBSG as judged by inhibition of activity. This interpretation is confirmed by the ability of S-hexyl glutathione to inhibit both catalysis of CHB conjugation and CHBSG sequestration of GST Al-2. Both effects were also seen in the presence of a mixture of potentially competing macromolecules, so they may well occur in cytosol. CHB and CHBSG. Recently the primary sequence of the murine alpha GST subunit (mYc) was obtained by Beutler and Eaton (1992) and it is clearly more closely related to the rat liver GST subunit 10 (Meyer et al., 1991b) and/or Yc2 (Hayes et al., 1991) rather than the major rat alpha GST subunits la, lb and 2. GST subunit 10 occurs mainly in foetal and neonatal rat liver (Tee et al., 1992) and may also be induced in adult liver by 1,2-dithiole-3-thione or ethoxyquin (Hayes et al., 1991) . It is possible that the alpha class GST associated with CHB-resistance in hamster cells (Lewis et al., 1988) is also more closely related to this type of alpha class subunit. To date, a human equivalent of mYc (or rat subunit 10/Yc2) has not been discovered.
In their study of human GSTs, Ciaccio et al. (1991) obtained kinetic data on the catalysis of the first GSH conjugation of CHB. They obtained Km values for CHB of 19, 150, 220 and 8301tM for GSTs Al-i, Al-2, A2-2 and P1-I respectively. These assays were carried out at lower, nonphysiological, pH (6.5) which reduces the relative contribution of the non-catalytic reaction rate and were terminated at 2.5 min before the inhibitory effects of CHBSG were apparent. The results presented here show that at physiological pH; with concentrations of salts, GSH and GSTs approximating those in cells, and amounts of CHB and time periods similar to those pertaining to chemotherapy, the catalysis of CHB conjugation with GSH is of marginal significance compared to the non-catalytic reaction. However, the sequestration of CHBSG is an important effect.
The significance of CHBSG sequestration cannot be readily assessed without further knowledge if its toxicity. When CHB was incubated with a crude soluble macromolecule fraction lacking GSTs and albumin, reduced recoveries of CHBSG, CHBSG2 and CHBSGOH were attributable to the alkylation of macromolecules by both CHB and the monofunctional CHBSG. When GST A1-2 was added, both its catalytic and sequestration effects were observed and the apparent alkylation of macromolecules was considerably reduced. The apparent alkylation due to CHBSG is likely to be of proteins rather than nucleic acids since no alkylation of guanine in DNA was observed with this compound.
Since GS-conjugates do not enter cells by diffusion, it is not possible to examine the toxicity of CHBSG formed inside the cell from CHB simply by adding CHBSG to cells. It has long been known that the monofunctional form of CHB (4-[p-N-2-chloroethylaminobenzene]-butanoic acid) is as toxic to normal cells as CHB (Connors et al., 1960) , but to what extent protein alkylation contributes to toxicity is unknown.
Despite these uncertainties, it may be surmised that the function of GSTs A1/2 in cells treated with CHB will tend to be inhibited by CHBSG. The extent of inhibition will depend on the concentrations of both the GSTs and CHBSG. The concentration of CHBSG will in turn depend on the capacity of the cell to export the conjugate via a plasma membrane ATP-dependent system (Ishikawa et al., 1990; Elferink et al., 1991; Singhal et al., 1991; Akerboom et al., 1992) . If CHBSG can be rapidly excreted without inactivating the transport system through alkylation, the presence of human alpha class GSTs at a concentration of 5-10I1M, as found for instance in ovarian carcinoma samples (Green et al., 1990) , would be expected to contribute significantly to CHB detoxication through direct catalysis of CHBSG formation. Protein alkylation by CHBSG should also be much reduced. If, however, CHBSG excretion is slow, CHBSG will rapidly accumulate and inhibit not only the catalytic detoxication of CHB but perhaps also other protective functions of alpha class GSTs such as the inhibition of lipid peroxidation via their selenium-independent GSH peroxidase activity (Tan et al., 1984) . In this case the GST should contribute little or nothing to protection against CHB toxicity. Variations in the relative concentrations of GSTs and CHBSG may thus explain the disparity between the results of Leyland-Jones et al. (1991) who found no CHB-protective effect of transfected human GST Al-I in MCF-7 cells and those of for example Puchalski and Fahl (1990) , who obtained positive results for rat alpha GST using transfection of mouse (1.2-foldresistant) and monkey cells (1.4-fold-resistant).
In order to achieve sensitisation to CHB of resistant cells, GST inhibitors such as ethacrynic acid have been used (Tew et al., 1988; Hansson et al., 1991) . Moreover, ethacrynic acid was recently used to inhibit GSTs in a phase I study (O'Dwyer et al., 1991) . The basis for such use was the low Ki value for human GSTs with ethacrynic acid and its GSconjugate in the range of 0.1-6pM (Ploeman et al, 1990) .
However, it is clear from the data presented here that a Ki of about 1 jAM is of little significance when the cellular concentration of GST is for example, 10 JAM as found in ovarian carcinoma samples (Green et al., 1990) . Thus 1O JM S-hexyl glutathione had no detectable effect on GST Al-2 when the latter was in molar excess ( Figure 5 ). The sensitisation to CHB due to ethacrynic acid may result not only from direct inhibition of activity, but also from competition between the GS-conjugates of ethacrynic acid and CHB for excretion. The studies presented in this paper emphasise that to inhibit GSTs in vivo it is important to consider both the relatively high molar concentration of these enzymes and cellular capacity to excrete GSH conjugates.
